|
Volumn 59, Issue 4, 2002, Pages 372-377
|
Efficacy of HMG-CoA reductase inhibitors in treating osteoporosis
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
3 HYDROXY 3 METHYLGLUTARYL COENZYME A;
ALENDRONIC ACID;
ANTILIPEMIC AGENT;
ATORVASTATIN;
BISPHOSPHONIC ACID DERIVATIVE;
BONE MORPHOGENETIC PROTEIN 2;
CALCITONIN;
CALCIUM;
CHOLESTEROL;
COMPACTIN;
CORTICOSTEROID;
ESTROGEN;
ESTROGEN RECEPTOR;
FIBRIC ACID DERIVATIVE;
FLUINDOSTATIN;
HEPARIN;
HYDROXYAPATITE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
MEVINOLIN;
PRAVASTATIN;
RALOXIFENE;
RISEDRONIC ACID;
SIMVASTATIN;
VITAMIN D;
BONE ATROPHY;
BONE DENSITY;
BONE MASS;
BONE MINERAL;
BONE RADIOGRAPHY;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
DRUG EFFICACY;
DUAL ENERGY X RAY ABSORPTIOMETRY;
ECHOGRAPHY;
FRACTURE;
HUMAN;
HYPERCHOLESTEROLEMIA;
NONHUMAN;
NOTE;
OSSIFICATION;
OSTEOLYSIS;
OSTEOPOROSIS;
PRIORITY JOURNAL;
RISK FACTOR;
|
EID: 0037083330
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.1093/ajhp/59.4.372 Document Type: Note |
Times cited : (4)
|
References (17)
|